FAST vs KLRS
Fastenal Company (FAST) versus Kalaris Therapeutics, Inc. (KLRS) — a side-by-side from cached financials, not a winner call.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Kalaris Therapeutics, Inc. (KLRS) is a biotechnology company listed on US.
Latest reported FAST revenue for 2026-06-30 was $4.59B. Net income was $722.6M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
KLRS does not have a complete income-statement cache yet.
FAST currently screens at market cap $49.48B and trailing P/E 43.1. KLRS currently screens at market cap $0.
Not investment advice. Open the FAST and KLRS stock pages for the full models.
Not investment advice.